Top Story

Robust antibiotic pipeline may require new thinking

September 20, 2014

WASHINGTON, D.C. — ICAAC 2014 keynote speaker John H. Rex, MD, senior vice president and head of infection, global medicines development at AstraZeneca, reviews the scientific, regulatory and economic hurdles of developing new antimicrobial agents, as well as examples of innovative approaches to overcoming some of these challenges.

Perspective

CDC: Enterovirus D68 continues to spread across US

September 19, 2014
The CDC has confirmed that enterovirus D68 has spread to 22 states, including the West Coast, infecting 160 people.Alabama, California, Colorado, Connecticut, Georgia…

NIH director: Emerging biomedical research ‘breathtaking’

September 19, 2014
NIH director Francis Collins, MD, PhD, spoke to the audience at TEDMED 2014 about the advances in biomedical research on the horizon.“I have this amazing…
Meeting News Coverage

HCV screenings at teaching clinic failed to meet CDC recommendation

September 19, 2014
NEW YORK — A majority of age-appropriate patients seen at a resident-run clinic were not screened for hepatitis C virus infection by physicians despite such a…
More News Headlines »
CME
figure

HCV Consults: Volume 1, Number 1

This activity is supported by educational grants from AbbVie and Genentech.

Physicians seldom experience a paradigm shift in disease management as great as that transpiring in HCV therapy. With…
More »
Meeting News Coverage Video
figure

Robust antibiotic pipeline may require new thinking

September 20, 2014
WASHINGTON, D.C. — ICAAC 2014 keynote speaker John H. Rex, MD, senior vice president and head of infection…
More »
CME
figure

HCV Consults: Volume 1, Number 2

This activity is supported by educational grants from AbbVie and Genentech.

Approved interferon-free therapy has already become entrenched among clinicians for patients with HCV genotypes 2 and…
More »